Salvage Therapy for Refractory Aids-Related Primary Central Nervous System Lymphoma
A 27-year-old male patient presented with speech disorders and multiple brain masses on MRI evaluation. He tested positive for HIV. A sterotactic biopsy diagnosed primary central nervous system lymphoma (diffuse large B-cell lymphoma). After two cycles of high-dose metotrexate (HD-MTX-)-based chemot...
Main Authors: | Hugo Ferro, Eduardo Parino |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/343491 |
Similar Items
-
Radiation therapy for primary central nervous system lymphoma
by: Yuta Shibamoto
Published: (2013-09-01) -
Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib
by: Cheng Q, et al.
Published: (2021-05-01) -
Current and emerging therapies for primary central nervous system lymphoma
by: Yan Yuan, et al.
Published: (2021-05-01) -
Histological verification of the treatment effect of tirabrutinib for relapsed/refractory primary central nervous system lymphoma
by: Yoshiko Okita, et al.
Published: (2021-04-01) -
Primary central nervous system lymphoma
by: Sarah Löw, et al.
Published: (2018-10-01)